PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL
Se. Oreilly et al., PHASE-I TRIAL OF RECOMBINANT HUMAN GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR DERIVED FROM YEAST IN PATIENTS WITH BREAST-CANCER RECEIVING CYCLOPHOSPHAMIDE, DOXORUBICIN, AND FLUOROURACIL, Journal of clinical oncology, 11(12), 1993, pp. 2411-2416